|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of net revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment losses | |||||
| Restructuring charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Loss on extinguishment of debt | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax provision (benefit) | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic ( in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Shares used to compute net loss per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...